EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Oxidative Stress and Antioxidant Therapies in Friedreich’s Ataxia

Félix Javier Jiménez-Jiménez iD, Hortensia Alonso-Navarro iD, Elena García-Martín iD, Alba Cárcamo-Fonfría iD, Miguel Angel Martín-Gómez iD, José A G Agúndez iD

Cells · 09.09.2025 · 14 (18) · 1406

DOI: 10.3390/cells14181406 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 09.09.2025. Verfasst von Félix Javier Jiménez-Jiménez und 5 weiteren Autor:innen. Beteiligte Einrichtung: Section of Neurology, Hospital Universitario del Sureste, Arganda del Rey, E 28500 Madrid, Spain. Hauptthemen laut MEDLINE: Friedreich Ataxia, Oxidative Stress, Antioxidants. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 168 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Fondo de Investigación Sanitaria, Instituto de Salud Carlos III, Madrid, Spain, FEDER.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The pathogenesis of Friedreich’s ataxia (FRDA) remains poorly understood. The most important event is the deficiency of frataxin, a protein related to iron metabolism and, therefore, involved in oxidative stress. Studies on oxidative stress markers and gene expression in FRDA patients have yielded inconclusive results. This is largely due to the limited number of studies, small sample sizes, and methodological differences. A notable finding is the decreased activity of mitochondrial respiratory chain complexes I, II, and III, as well as aconitase, in endomyocardial tissue. In contrast, numerous studies in experimental models of FRDA (characterized by frataxin deficiency) have shown evidence of the involvement of oxidative stress in cellular degeneration. These findings include increased iron concentration, mitochondrial dysfunction (with reduced respiratory chain complex activity and membrane potential), and decreased aconitase activity. Additionally, there is the induction of antioxidant enzymes, reduced glutathione levels, elevated markers of lipoperoxidation, and DNA and carbonyl protein oxidation. The expression of NRF2 is decreased, along with the downregulation of PGC-1α. Therefore, it is plausible that antioxidant treatment may help improve symptoms and slow the progression of FRDA. Among the antioxidant treatments tested in FRDA patients, only omaveloxolone and, to a lesser extent, idebenone (particularly for cardiac hypertrophy) have shown some efficacy. However, many antioxidant drugs have shown the ability to reduce oxidative stress in experimental models of FRDA. Therefore, these drugs may be useful in treating FRDA and are likely candidates for future clinical trials. Future studies investigating oxidative stress and antioxidant therapies in FRDA should adopt a prospective, multicenter, long-term, double-blind design.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Friedreich AtaxiaOxidative StressAntioxidantsHumansAnimalsMitochondria

Stichwörter der Autor:innen

Friedreich’s ataxiaanimal modelsbiological markersfrataxinoxidative stresspathogenesis

Substanzen

Antioxidants

Autor:innen und Institutionen

  • Section of Neurology, Hospital Universitario del Sureste, Arganda del Rey, E 28500 Madrid, Spain.
  • University Institute of Molecular Pathology Biomarkers, Universidad de Extremadura, E 10071 Caceres, Spain.

ORCID-Profile: Félix Javier Jiménez-Jiménez, Hortensia Alonso-Navarro, Elena García-Martín, Alba Cárcamo-Fonfría, Miguel Angel Martín-Gómez, José A G Agúndez

Förderung

  • Instituto de Salud Carlos III
  • Fondo de Investigación Sanitaria, Instituto de Salud Carlos III, Madrid, Spain
  • FEDER

Zitieren

APA

Jiménez-Jiménez, F. J., Alonso-Navarro, H., García-Martín, E., Cárcamo-Fonfría, A., Martín-Gómez, M. A., & Agúndez, J. A. G. (2025). Oxidative Stress and Antioxidant Therapies in Friedreich’s Ataxia. Cells, 14(18), 1406. https://doi.org/10.3390/cells14181406

Vancouver

Jiménez-Jiménez FJ, Alonso-Navarro H, García-Martín E, Cárcamo-Fonfría A, Martín-Gómez MA, Agúndez JAG. Oxidative Stress and Antioxidant Therapies in Friedreich’s Ataxia. Cells. 2025;14(18):1406. doi:10.3390/cells14181406

BibTeX
@article{JimnezJimnez2025,
  author = {Jiménez-Jiménez, Félix Javier and Alonso-Navarro, Hortensia and García-Martín, Elena and Cárcamo-Fonfría, Alba and Martín-Gómez, Miguel Angel and Agúndez, José A G},
  title = {Oxidative Stress and Antioxidant Therapies in Friedreich’s Ataxia},
  journal = {Cells},
  year = {2025},
  volume = {14},
  number = {18},
  pages = {1406},
  doi = {10.3390/cells14181406}
}
Kostenlos starten →